BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34030576)

  • 1. The role of inflammatory parameters in predicting disease recurrence in patients with stage IIA colon cancer with no high-risk features.
    Erdur E; Yildirim OA; Poyraz K; Aslan F; Yıldız F; Kömek H
    Postgrad Med; 2021 Aug; 133(6):694-700. PubMed ID: 34030576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative prognostic nutritional index predicts risk of recurrence after curative resection for stage IIA colon cancer.
    Maruyama T; Shimoda M; Hakoda H; Sako A; Ueda K; Suzuki S
    Am J Surg; 2021 Jul; 222(1):179-185. PubMed ID: 33138968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
    Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment C-reactive protein/albumin ratio is associated with poor survival in patients with stage IB-IIA cervical cancer.
    Zhang W; Liu K; Ye B; Liang W; Ren Y
    Cancer Med; 2018 Jan; 7(1):105-113. PubMed ID: 29193777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
    Song A; Eo W; Lee S
    World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of lymph node count and positivity in patients undergoing surgery for colon cancer.
    Dolan RD; McSorley ST; Horgan PG; McMillan DC
    Medicine (Baltimore); 2018 Mar; 97(13):e0185. PubMed ID: 29595652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of systemic inflammation in patients undergoing surgery for colon cancer: comparison of composite ratios and cumulative scores.
    Dolan RD; McSorley ST; Park JH; Watt DG; Roxburgh CS; Horgan PG; McMillan DC
    Br J Cancer; 2018 Jul; 119(1):40-51. PubMed ID: 29789606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein-albumin ratio is an independent prognostic predictor of tumor recurrence in stage IIIA-N2 lung adenocarcinoma patients.
    Yamauchi Y; Safi S; Muley T; Warth A; Herth FJF; Dienemann H; Hoffmann H; Eichhorn ME
    Lung Cancer; 2017 Dec; 114():62-67. PubMed ID: 29173768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
    Shao N; Cai Q
    Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer.
    Ding PR; An X; Zhang RX; Fang YJ; Li LR; Chen G; Wu XJ; Lu ZH; Lin JZ; Kong LH; Wan DS; Pan ZZ
    Int J Colorectal Dis; 2010 Dec; 25(12):1427-33. PubMed ID: 20821217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment C-Reactive Protein/Albumin Ratio is Associated With Poor Survival in Patients With 2018 FIGO Stage IB-IIA HPV-Positive Cervical Cancer.
    Jiang Y; Gu H; Zheng X; Pan B; Liu P; Zheng M
    Pathol Oncol Res; 2021; 27():1609946. PubMed ID: 34992504
    [No Abstract]   [Full Text] [Related]  

  • 12. Postoperative C-reactive protein/albumin ratio is a biomarker of risk of recurrence and need for adjuvant chemotherapy for stage III colorectal cancer.
    Matsuoka H; Ando K; Hu Q; Zaitsu Y; Tsuda Y; Hisamatsu Y; Nakashima Y; Kimura Y; Oki E; Mori M
    Int J Clin Oncol; 2020 Jul; 25(7):1318-1326. PubMed ID: 32279124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Inflammatory Biomarkers as Surrogate Markers for Stage in Colon Cancer.
    Uludag SS; Sanli AN; Zengin AK; Ozcelik MF
    Am Surg; 2022 Jun; 88(6):1256-1262. PubMed ID: 33596111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil to lymphocyte ratio is a strong predictor of tumor recurrence in early colon cancers: A propensity score-matched analysis.
    Galizia G; Lieto E; Zamboli A; De Vita F; Castellano P; Romano C; Auricchio A; Cardella F; De Stefano L; Orditura M
    Surgery; 2015 Jul; 158(1):112-20. PubMed ID: 25818659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Comparative Analysis of Prognostic Value of Systemic Inflammatory Biomarkers for Patients with Stage II/III Colon Cancer.
    Suzuki S; Akiyoshi T; Oba K; Otsuka F; Tominaga T; Nagasaki T; Fukunaga Y; Ueno M
    Ann Surg Oncol; 2020 Mar; 27(3):844-852. PubMed ID: 31720937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy.
    Miao Y; Yan Q; Li S; Li B; Feng Y
    Cancer Biomark; 2016 Jun; 17(1):33-40. PubMed ID: 27314290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive values of the postoperative neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio for the diagnosis of early periprosthetic joint infections: a preliminary study.
    Zhao G; Chen J; Wang J; Wang S; Xia J; Wei Y; Wu J; Huang G; Chen F; Shi J; Lyu J; Liu C; Huang X
    J Orthop Surg Res; 2020 Nov; 15(1):571. PubMed ID: 33256763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low Pretreatment Lymphocyte-Monocyte Ratio and High Platelet-Lymphocyte Ratio Indicate Poor Cancer Outcome in Early Tongue Cancer.
    Ong HS; Gokavarapu S; Wang LZ; Tian Z; Zhang CP
    J Oral Maxillofac Surg; 2017 Aug; 75(8):1762-1774. PubMed ID: 28063763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral platelet/lymphocyte ratio predicts lymph node metastasis and acts as a superior prognostic factor for cervical cancer when combined with neutrophil: Lymphocyte.
    Chen L; Zhang F; Sheng XG; Zhang SQ; Chen YT; Liu BW
    Medicine (Baltimore); 2016 Aug; 95(32):e4381. PubMed ID: 27512849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic impact of neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) in patients with distal bile duct cancer.
    Miyahara Y; Takashi S; Shimizu Y; Ohtsuka M
    World J Surg Oncol; 2020 Apr; 18(1):78. PubMed ID: 32321522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.